However, heterogeneity test in 3,000 mg group showed higher inconsistency ( I 2 =52.2%, P =0.10) than 2,000 mg/day group ( I 2 =0.0%, P =0.67), but it did not reach statistical significance.
← all excerpts
A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with refractory epilepsy.
1
—
—